Lauren Stival | Investor Relations |
Mike Anderson | Chief Executive Officer |
Mike Kanan | Chief Financial Officer |
Greg Divis | Chief Operating Officer |
Matt Kaplan | Ladenburg Thalmann |
John Boris | SunTrust |
François Brisebois | Laidlaw |
Good morning, ladies and gentlemen and welcome to the Avadel Pharmaceuticals’ Third Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call maybe recorded. I would now like to introduce your host for today’s conference, Ms.